Nabtesco Corporation Share Price Other OTC
Stocks
NCTKF
JP3651210001
Industrial Machinery & Equipment
OTC Markets Traded| Market Cap | 56TCr 350.87Cr 308.62Cr 290.93Cr 265.44Cr 496.4Cr 34TCr 500.26Cr 3.49TCr 1.35TCr 17TCr 1.32TCr 1.29TCr | P/E 2026 * |
22.6x | P/E 2027 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise Value | 53TCr 332.26Cr 292.26Cr 275.51Cr 251.36Cr 470.08Cr 32TCr 473.74Cr 3.31TCr 1.28TCr 16TCr 1.25TCr 1.22TCr | EV / Sales 2026 * |
1.52x | EV / Sales 2027 * | 1.4x |
| Free-Float |
91.23% | Yield 2026 * |
1.73% | Yield 2027 * | 1.9% |
| 1 day | +0.77% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kazumasa Kimura
CEO | Chief Executive Officer | 65 | 01/03/2022 |
Hiroshi Usui
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/01/2025 |
Michi Suzuki
PRN | Corporate Officer/Principal | 63 | 01/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Kazumasa Kimura
BRD | Director/Board Member | 65 | 01/03/2019 |
Mari Iizuka
BRD | Director/Board Member | 67 | 01/03/2020 |
Naoko Mizukoshi
BRD | Director/Board Member | 59 | 01/03/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.77% | -.--% | - | - | 341.91Cr | ||
| +0.39% | +5.37% | +30.21% | +149.03% | 12TCr | ||
| +2.89% | +3.13% | +38.35% | +51.82% | 3.45TCr | ||
| -1.89% | +2.93% | -7.58% | +16.26% | 2.96TCr | ||
| +3.29% | +0.97% | +53.96% | +1.23% | 2.63TCr | ||
| -5.50% | -4.59% | -27.43% | +12.83% | 2.54TCr | ||
| -0.60% | -0.71% | +12.31% | +31.82% | 2.55TCr | ||
| -3.41% | -7.31% | +369.05% | +1,863.68% | 2.45TCr | ||
| -0.18% | +2.19% | +26.92% | +52.90% | 2.34TCr | ||
| +0.27% | +3.22% | - | - | 2.2TCr | ||
| Average | -0.35% | +1.31% | +61.97% | +272.44% | 3.71TCr | |
| Weighted average by Cap. | -0.13% | +2.66% | +49.77% | +220.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 35TCr 218.25Cr 191.97Cr 180.97Cr 165.11Cr 308.78Cr 21TCr 311.18Cr 2.17TCr 841.55Cr 11TCr 819.44Cr 801.65Cr | 37TCr 229.88Cr 202.2Cr 190.61Cr 173.91Cr 325.23Cr 22TCr 327.76Cr 2.29TCr 886.39Cr 11TCr 863.1Cr 844.36Cr |
| Net income | 2.45TCr 15Cr 14Cr 13Cr 12Cr 22Cr 1.48TCr 22Cr 153.14Cr 59Cr 751.9Cr 58Cr 57Cr | 2.64TCr 17Cr 15Cr 14Cr 13Cr 24Cr 1.6TCr 24Cr 165.4Cr 64Cr 812.09Cr 62Cr 61Cr |
| Net Debt | -2.96TCr -19Cr -16Cr -15Cr -14Cr -26Cr -1.79TCr -27Cr -185.1Cr -72Cr -908.82Cr -70Cr -68Cr | -4.76TCr -30Cr -26Cr -25Cr -23Cr -42Cr -2.87TCr -43Cr -297.76Cr -115.38Cr -1.46TCr -112.35Cr -109.91Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















